Cannabis Investment Report | December 2017 m U.S. Legalized Cannabis Market Forecast Forecast Methodology The cannabis industry is driven by consumers, similar to other highly regulated industries such as alco- hol, tobacco and pharmaceuticals. Consequently, our methodology fo...
Results for “Regeneron Pharmaceuticals”
Search across the indexed text of every released document.
Names that match “Regeneron Pharmaceuticals”
49 documents found
Sprout Capital VIL, L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes 1,],K,L,M and N in this Appendix. Gross Multiple Gross Vintage Total Realized Unrealize Total (Realized Multiple Company Year Cost Value d Value Valu...
ACKRELL CAPITAL THE GREEN FIELD 2018 Consumer Products Flower and Concentrates oshatan iene FRESH cicct A prereryayrenye as MEDICINALS a dama ~~ Greenoor’ (TOPHMAARMS ots ae wifi ‘ao — hs WINK a “a a. Le son _— Ne eae ik Rake: oa can SHANGO ~~ an 1 AR eee [ost vere] FARE S wy...
ACKR CAPI CHAPTER VI U.S. and International Cannabis Market Estimates U.S. Legalized Cannabis Market Estimates Based on our assumptions and methodology, we believe that the U.S. legalized cannabis market will ultimately exceed $100 billion annually, with more than 50 million co...